Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Comparison of 36 assisted reproduction laboratories monitoring environmental conditions and instrument parameters using the same quality-control application.

Palmer GA, Kratka C, Szvetecz S, Fiser G, Fiser S, Sanders C, Tomkin G, Szvetecz MA, Cohen J.

Reprod Biomed Online. 2019 Jul;39(1):63-74. doi: 10.1016/j.rbmo.2019.03.204. Epub 2019 Mar 16.

2.

A Comparison Between the Involuntary and Voluntary Treatment of Patients With Alcohol Use Disorder in a Residential Rehabilitation Treatment Program.

Boit H, Palmer GA, Olson SA.

J Addict Nurs. 2019 Jan/Mar;30(1):57-60. doi: 10.1097/JAN.0000000000000248.

PMID:
30830001
3.
4.

Use of Chlorhexidine to Prevent Ventilator-Associated Pneumonia in a Long-term Care Setting: A Retrospective Medical Record Review.

McCue MK, Palmer GA.

J Nurs Care Qual. 2019 Jul/Sep;34(3):263-268. doi: 10.1097/NCQ.0000000000000367. Review.

PMID:
30325851
5.

Improving Nursing Confidence and Consistency in Assessment of Opioid Withdrawal: Efficacy of Simulation and Debriefing.

Corrigan D, Mix RL, Palmer GA, Olson SA.

J Psychosoc Nurs Ment Health Serv. 2018 Oct 1;56(10):27-35. doi: 10.3928/02793695-20180503-05. Epub 2018 May 9.

PMID:
29741749
6.

Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.

Ross JS, Ali SM, Wang K, Khaira D, Palma NA, Chmielecki J, Palmer GA, Morosini D, Elvin JA, Fernandez SV, Miller VA, Stephens PJ, Cristofanilli M.

Breast Cancer Res Treat. 2015 Nov;154(1):155-62. doi: 10.1007/s10549-015-3592-z. Epub 2015 Oct 12.

PMID:
26458824
7.

Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.

Ali SM, Sanford EM, Klempner SJ, Rubinson DA, Wang K, Palma NA, Chmielecki J, Yelensky R, Palmer GA, Morosini D, Lipson D, Catenacci DV, Braiteh F, Erlich R, Stephens PJ, Ross JS, Ou SH, Miller VA.

Oncologist. 2015 May;20(5):499-507. doi: 10.1634/theoncologist.2014-0378. Epub 2015 Apr 16.

8.

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.

Pekar-Zlotin M, Hirsch FR, Soussan-Gutman L, Ilouze M, Dvir A, Boyle T, Wynes M, Miller VA, Lipson D, Palmer GA, Ali SM, Dekel S, Brenner R, Bunn PA Jr, Peled N.

Oncologist. 2015 Mar;20(3):316-22. doi: 10.1634/theoncologist.2014-0389. Epub 2015 Feb 26.

9.

Morphokinetic parameters of early embryo development via time lapse monitoring and their effect on embryo selection and ICSI outcomes: a prospective cohort study.

Siristatidis C, Komitopoulou MA, Makris A, Sialakouma A, Botzaki M, Mastorakos G, Salamalekis G, Bettocchi S, Palmer GA.

J Assist Reprod Genet. 2015 Apr;32(4):563-70. doi: 10.1007/s10815-015-0436-z. Epub 2015 Jan 24.

10.

Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.

Chmielecki J, Ross JS, Wang K, Frampton GM, Palmer GA, Ali SM, Palma N, Morosini D, Miller VA, Yelensky R, Lipson D, Stephens PJ.

Oncologist. 2015 Jan;20(1):7-12. doi: 10.1634/theoncologist.2014-0234. Epub 2014 Dec 5.

11.

Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials.

Said R, Ye Y, Falchook GS, Janku F, Naing A, Zinner R, Blumenschein GR Jr, Fu S, Hong DS, Piha-Paul SA, Wheler JJ, Kurzrock R, Palmer GA, Aldape K, Hess KR, Tsimberidou AM.

Oncotarget. 2014 Oct 15;5(19):8937-46.

12.

Outcome analysis of hemoglobin A1c, weight, and blood pressure in a VA diabetes education program.

North SL, Palmer GA.

J Nutr Educ Behav. 2015 Jan-Feb;47(1):28-35. doi: 10.1016/j.jneb.2014.07.006. Epub 2014 Sep 27.

PMID:
25270973
13.

Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.

Palma NA, Ali SM, O'Connor J, Dutta D, Wang K, Soman S, Palmer GA, Morosini D, Ross JS, Lipson D, Stephens PJ, Patel M, Miller VA, Koutrelakos N.

Case Rep Oncol. 2014 Jul 23;7(2):503-8. doi: 10.1159/000365326. eCollection 2014 May.

14.

Psychometric properties of the Beck Depression Inventory-II for OEF/OIF veterans in a polytrauma sample.

Palmer GA, Happe MC, Paxson JM, Jurek BK, Graca JJ, Olson SA.

Mil Med. 2014 Aug;179(8):879-84. doi: 10.7205/MILMED-D-14-00048.

PMID:
25102530
15.

Characteristics and survival of patients with advanced cancer and p53 mutations.

Said R, Ye Y, Hong DS, Janku F, Fu S, Naing A, Wheler JJ, Kurzrock R, Thomas C, Palmer GA, Hess KR, Aldape K, Tsimberidou AM.

Oncotarget. 2014 Jun 15;5(11):3871-9.

16.

Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.

Sharman JP, Chmielecki J, Morosini D, Palmer GA, Ross JS, Stephens PJ, Stafl J, Miller VA, Ali SM.

Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):e161-3. doi: 10.1016/j.clml.2014.06.004. Epub 2014 Jun 11. No abstract available.

PMID:
24997557
17.

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.

Ali SM, He J, Carson W, Stephens PJ, Fiorillo J, Lipson D, Palmer GA, Ross JS, Miller VA, Sharman J.

Case Rep Oncol. 2014 May 24;7(2):343-8. doi: 10.1159/000363377. eCollection 2014 May.

18.

Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.

Ganesan P, Ali SM, Wang K, Blumenschein GR, Esmaeli B, Wolff RA, Miller VA, Stephens PJ, Ross JS, Palmer GA, Janku F.

J Clin Oncol. 2016 Feb 10;34(5):e34-7. doi: 10.1200/JCO.2013.50.3516. Epub 2014 Jun 16. No abstract available.

PMID:
24934779
19.

Measuring chronic pain intensity among veterans in a residential rehabilitation treatment program.

Randleman ML, Douglas ME, DeLane AM, Palmer GA.

J Addict Nurs. 2014 Apr-Jun;25(2):74-80. doi: 10.1097/JAN.0000000000000027.

PMID:
24905756
20.

Concordance of genomic alterations between primary and recurrent breast cancer.

Meric-Bernstam F, Frampton GM, Ferrer-Lozano J, Yelensky R, Pérez-Fidalgo JA, Wang Y, Palmer GA, Ross JS, Miller VA, Su X, Eroles P, Barrera JA, Burgues O, Lluch AM, Zheng X, Sahin A, Stephens PJ, Mills GB, Cronin MT, Gonzalez-Angulo AM.

Mol Cancer Ther. 2014 May;13(5):1382-9. doi: 10.1158/1535-7163.MCT-13-0482. Epub 2014 Mar 7.

21.

Determining pain scale preference in a veteran population experiencing chronic pain.

Douglas ME, Randleman ML, DeLane AM, Palmer GA.

Pain Manag Nurs. 2014 Sep;15(3):625-31. doi: 10.1016/j.pmn.2013.06.003. Epub 2014 Feb 14.

PMID:
24530196
22.

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy.

Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M.

J Clin Oncol. 2014 Sep 1;32(25):e88-91. doi: 10.1200/JCO.2013.49.0599. Epub 2014 Feb 10. No abstract available.

23.

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.

Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ, Palmer GA, Ali SM.

J Hematol Oncol. 2014 Jan 14;7:8. doi: 10.1186/1756-8722-7-8.

24.

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.

Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, Sánchez V, Kurupi R, Moore PD, Pinto JA, Doimi FD, Gómez H, Horiuchi D, Goga A, Lehmann BD, Bauer JA, Pietenpol JA, Ross JS, Palmer GA, Yelensky R, Cronin M, Miller VA, Stephens PJ, Arteaga CL.

Cancer Discov. 2014 Feb;4(2):232-45. doi: 10.1158/2159-8290.CD-13-0286. Epub 2013 Dec 19.

25.

Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib.

Ali SM, Alpaugh RK, Buell JK, Stephens PJ, Yu JQ, Wu H, Hiemstra CN, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M.

Clin Breast Cancer. 2014 Feb;14(1):e14-6. doi: 10.1016/j.clbc.2013.09.010. Epub 2013 Sep 27. No abstract available.

PMID:
24201163
26.

Synthetic generation of influenza vaccine viruses for rapid response to pandemics.

Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, Dattilo BM, Denisova EA, De Souza I, Eickmann M, Dugan VG, Ferrari A, Gomila RC, Han L, Judge C, Mane S, Matrosovich M, Merryman C, Palladino G, Palmer GA, Spencer T, Strecker T, Trusheim H, Uhlendorff J, Wen Y, Yee AC, Zaveri J, Zhou B, Becker S, Donabedian A, Mason PW, Glass JI, Rappuoli R, Venter JC.

Sci Transl Med. 2013 May 15;5(185):185ra68. doi: 10.1126/scitranslmed.3006368.

27.

Hairy roots as a vaccine production and delivery system.

Skarjinskaia M, Ruby K, Araujo A, Taylor K, Gopalasamy-Raju V, Musiychuk K, Chichester JA, Palmer GA, de la Rosa P, Mett V, Ugulava N, Streatfield SJ, Yusibov V.

Adv Biochem Eng Biotechnol. 2013;134:115-34. doi: 10.1007/10_2013_184. Review.

PMID:
23649385
28.

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease.

Shaw CA, Galarneau JR, Bowenkamp KE, Swanson KA, Palmer GA, Palladino G, Markovits JE, Valiante NM, Dormitzer PR, Otten GR.

Vaccine. 2013 Jan 2;31(2):306-12. doi: 10.1016/j.vaccine.2012.11.006. Epub 2012 Nov 12.

PMID:
23153444
29.

An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.

Shoji Y, Chichester JA, Palmer GA, Farrance CE, Stevens R, Stewart M, Goldschmidt L, Deyde V, Gubareva L, Klimov A, Mett V, Yusibov V.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:199-204.

PMID:
21922687
30.

Antibody affinity maturation and respiratory syncytial virus disease.

Shaw CA, Otten G, Wack A, Palmer GA, Mandl CW, Mbow ML, Valiante N, Dormitzer PR.

Nat Med. 2009 Jul;15(7):725; author reply 725-6. doi: 10.1038/nm0709-725a. No abstract available.

PMID:
19584854
31.

Plant-expressed HA as a seasonal influenza vaccine candidate.

Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, Yusibov V.

Vaccine. 2008 Jun 2;26(23):2930-4. doi: 10.1016/j.vaccine.2008.03.045. Epub 2008 Apr 9.

PMID:
18440103
32.

A plant-produced influenza subunit vaccine protects ferrets against virus challenge.

Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, Shoji Y, de la Rosa P, Palmer GA, Rabindran S, Streatfield SJ, Boyers A, Russell M, Mann A, Lambkin R, Oxford JS, Schild GC, Yusibov V.

Influenza Other Respir Viruses. 2008 Jan;2(1):33-40. doi: 10.1111/j.1750-2659.2008.00037.x.

33.

A plant-produced plague vaccine candidate confers protection to monkeys.

Mett V, Lyons J, Musiychuk K, Chichester JA, Brasil T, Couch R, Sherwood R, Palmer GA, Streatfield SJ, Yusibov V.

Vaccine. 2007 Apr 20;25(16):3014-7. Epub 2007 Jan 22.

PMID:
17287055
34.

Immunogenicity of a subunit vaccine against Bacillus anthracis.

Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.

Vaccine. 2007 Apr 20;25(16):3111-4. Epub 2007 Jan 22.

PMID:
17280756
35.

Neuropsychological profiles of persons with mental retardation and dementia.

Palmer GA.

Res Dev Disabil. 2006 May-Jun;27(3):299-308. Epub 2005 Jul 27.

PMID:
16054334
37.

Differential regulation of SOCS genes in normal and transformed erythroid cells.

Sarna MK, Ingley E, Busfield SJ, Cull VS, Lepere W, McCarthy DJ, Wright MJ, Palmer GA, Chappell D, Sayer MS, Alexander WS, Hilton DJ, Starr R, Watowich SS, Bittorf T, Klinken SP, Tilbrook PA.

Oncogene. 2003 May 22;22(21):3221-30.

38.

Pregnancies following blastocyst stage transfer in PGD cycles at risk for beta-thalassaemic haemoglobinopathies.

Palmer GA, Traeger-Synodinos J, Davies S, Tzetis M, Vrettou C, Mastrominas M, Kanavakis E.

Hum Reprod. 2002 Jan;17(1):25-31.

PMID:
11756357
39.

Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.

Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.

Cancer Res. 2001 Mar 15;61(6):2453-8.

40.

Autonomous parvoviruses as gene transfer vehicles.

Palmer GA, Tattersall P.

Contrib Microbiol. 2000;4:178-202. Review. No abstract available.

PMID:
10941578
41.
42.
45.

Sequence of the genome of lactate dehydrogenase-elevating virus: heterogenicity between strains P and C.

Palmer GA, Kuo L, Chen Z, Faaberg KS, Plagemann PG.

Virology. 1995 Jun 1;209(2):637-42.

46.

Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.

Anderson GW, Palmer GA, Rowland RR, Even C, Plagemann PG.

J Gen Virol. 1995 Mar;76 ( Pt 3):581-92.

PMID:
7897349
47.
49.

The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.

Chan CK, Kempin SJ, Noble SK, Palmer GA.

Ophthalmology. 1994 Feb;101(2):289-300.

PMID:
7509472
50.

Breast cancer: diagnosis and treatment.

Palmer GA.

Nurse Pract Forum. 1993 Jun;4(2):100-4.

PMID:
8513260

Supplemental Content

Loading ...
Support Center